Grupp SA - Search Results

1

Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19.

Asnani M, Hayer KE, Naqvi AS, Zheng S, Yang SY, Oldridge D, Ibrahim F, Maragkakis M, Gazzara MR, Black KL, Bagashev A, Taylor D, Mourelatos Z, Grupp SA, Barrett D, Maris JM, Sotillo E, Barash Y, Thomas-Tikhonenko A. Asnani M, et al. Among authors: grupp sa. Leukemia. 2020 Apr;34(4):1202-1207. doi: 10.1038/s41375-019-0580-z. Epub 2019 Oct 7. Leukemia. 2020. PMID: 31591467 Free PMC article. No abstract available.

2

Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.

Shusterman S, Grupp SA, Maris JM. Shusterman S, et al. Among authors: grupp sa. Med Pediatr Oncol. 2000 Dec;35(6):673-6. doi: 10.1002/1096-911x(20001201)35:6<673::aid-mpo41>3.0.co;2-o. Med Pediatr Oncol. 2000. PMID: 11107144

3

The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.

Shusterman S, Grupp SA, Barr R, Carpentieri D, Zhao H, Maris JM. Shusterman S, et al. Among authors: grupp sa. Clin Cancer Res. 2001 Apr;7(4):977-84. Clin Cancer Res. 2001. PMID: 11309349

4

Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma.

Coughlin CM, Fleming MD, Carroll RG, Pawel BR, Hogarty MD, Shan X, Vance BA, Cohen JN, Jairaj S, Lord EM, Wexler MH, Danet-Desnoyers GA, Pinkus JL, Pinkus GS, Maris JM, Grupp SA, Vonderheide RH. Coughlin CM, et al. Among authors: grupp sa. J Clin Oncol. 2006 Dec 20;24(36):5725-34. doi: 10.1200/JCO.2005.05.3314. J Clin Oncol. 2006. PMID: 17179106

5

Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.

Seif AE, Barrett DM, Milone M, Brown VI, Grupp SA, Reid GS. Seif AE, et al. Among authors: grupp sa. Blood. 2009 Sep 17;114(12):2459-66. doi: 10.1182/blood-2009-02-203984. Epub 2009 Jul 27. Blood. 2009. PMID: 19636062 Free PMC article.

6

Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.

Barrett D, Fish JD, Grupp SA. Barrett D, et al. Among authors: grupp sa. Pediatr Clin North Am. 2010 Feb;57(1):47-66. doi: 10.1016/j.pcl.2010.01.001. Pediatr Clin North Am. 2010. PMID: 20307711 Free PMC article. Review.

7

Treatment of advanced leukemia in mice with mRNA engineered T cells.

Barrett DM, Zhao Y, Liu X, Jiang S, Carpenito C, Kalos M, Carroll RG, June CH, Grupp SA. Barrett DM, et al. Among authors: grupp sa. Hum Gene Ther. 2011 Dec;22(12):1575-86. doi: 10.1089/hum.2011.070. Epub 2011 Sep 23. Hum Gene Ther. 2011. PMID: 21838572 Free PMC article.

8

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.

Barrett DM, Seif AE, Carpenito C, Teachey DT, Fish JD, June CH, Grupp SA, Reid GS. Barrett DM, et al. Among authors: grupp sa. Blood. 2011 Oct 13;118(15):e112-7. doi: 10.1182/blood-2011-04-346528. Epub 2011 Aug 19. Blood. 2011. PMID: 21856863 Free PMC article.

9

The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer.

Lee DW, Barrett DM, Mackall C, Orentas R, Grupp SA. Lee DW, et al. Among authors: grupp sa. Clin Cancer Res. 2012 May 15;18(10):2780-90. doi: 10.1158/1078-0432.CCR-11-1920. Clin Cancer Res. 2012. PMID: 22589486 Free PMC article.

10

Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies.

Barrett D, Brown VI, Grupp SA, Teachey DT. Barrett D, et al. Among authors: grupp sa. Paediatr Drugs. 2012 Oct 1;14(5):299-316. doi: 10.2165/11594740-000000000-00000. Paediatr Drugs. 2012. PMID: 22845486 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page